{
  "id": 2460745,
  "title": "Zurn Elkay director Jacques Butler buys $99,993 in company stock",
  "url": "https://urgent.news/2026/08/22/zurn-elkay-director-jacques-butler-buys-99-993-in-company-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-22T00:31:02.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/zurn-elkay-director-jacques-butler-buys-99993-in-company-stock-93CH-4872235"
  },
  "original_language": "en",
  "account": "Jacques Butler, a director of Zurn Elkay Water Solutions Corp, acquired 2,016 shares of the company's stock on August 19, 2026, for $49.6 per share. This purchase, totaling $99,993, came shortly after the company's strong second-quarter performance in 2026, surpassing analysts' expectations with adjusted earnings of $0.50 per share and revenue of $491 million. Zurn Elkay's market capitalization stands at $8.1 billion, with a price-to-earnings ratio of 30.38. After the insider transaction, Mr. Butler now directly owns 37,487 shares of the company's common stock. The purchase was officially reported in a Form 4 filing with the Securities and Exchange Commission on August 21, 2026. ZWS's financial health is excellent, as indicated by its perfect Piotroski Score of 9. The company is among over 1,400 US equities with detailed Pro Research Reports, providing actionable insights. Stifel has maintained a Buy rating on Zurn Water Solutions, with a price target of $62. The company is focusing on niche markets valued between $100 million and $200 million, aiming to capture a market share of 10% to 15% within two to three years.",
  "summary": null,
  "key_points": [
    "Jacques Butler bought 2,016 shares of Zurn Elkay at $49.6 per share on August 19, 2026.",
    "The purchase totaled $99,993, following the company's strong Q2 2026 performance.",
    "Butler now owns 37,487 shares, increasing his stake after the insider transaction."
  ],
  "editors_take": "The insider purchase signals confidence in Zurn Elkay's financial health and growth prospects, particularly after its strong quarterly performance that surpassed analyst expectations.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}